Current Advances in the Use of Nanophytomedicine Therapies for Human Cardiovascular Diseases

por Hesari M, Mohammadi P, Khademi F, Shackebaei D, Momtaz S, Moasefi N, Farzaei MH, Abdollahi M
Publicado 2021

Nanoformulations of natural products for management of metabolic syndrome

por Taghipour YD, Hajialyani M, Naseri R, Hesari M, Mohammadi P, Stefanucci A, Mollica A, Farzaei MH, Abdollahi M
Publicado 2019

Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

por Mosselhy DA, He W, Hynönen U, Meng Y, Mohammadi P, Palva A, Feng Q, Hannula SP, Nordström K, Linder MB
Publicado 2018

Silica–gentamicin nanohybrids: combating antibiotic resistance, bacterial biofilms, and in vivo toxicity

por Mosselhy DA, He W, Hynönen U, Meng Y, Mohammadi P, Palva A, Feng QL, Hannula SP, Nordström K, Linder MB
Publicado 2018